Cargando…

Effectiveness of Dupilumab in the Treatment of Adult and Older Adult Patients with Severe, Uncontrolled CRSwNP

Chronic rhinosinusitis with nasal polyps (CRSwNP) is a multifactorial disease that significantly impacts patients’ quality of life. New therapeutic strategies and in particular biologic treatments are now available for these patients. It has been demonstrated that Dupilumab (an anti IL-4/IL-13 biolo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ottaviano, Giancarlo, De Corso, Eugenio, Saccardo, Tommaso, D’Auria, Leandro Maria, Zampollo, Sonny, D’Agostino, Giuseppe, Mairani, Edoardo, De Maio, Gabriele, Scarpa, Bruno, Bacci, Christian, Favero, Vittorio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10456067/ https://www.ncbi.nlm.nih.gov/pubmed/37623491 http://dx.doi.org/10.3390/jpm13081241

Ejemplares similares

Measuring Nasal Patency and the Sense of Smell in CRSwNP Patients Treated with Dupilumab
por: Ottaviano, Giancarlo, et al.
Publicado: (2023)

Effectiveness of Dupilumab in the Treatment of Patients with Uncontrolled Severe CRSwNP: A “Real-Life” Observational Study in Naïve and Post-Surgical Patients
por: Ottaviano, Giancarlo, et al.
Publicado: (2022)

Olfaction Recovery following Dupilumab Is Independent of Nasal Polyp Reduction in CRSwNP
por: Cantone, Elena, et al.
Publicado: (2022)

Rapid and Continuing Improvements in Nasal Symptoms with Dupilumab in Patients with Severe CRSwNP
por: Bachert, Claus, et al.
Publicado: (2022)

Eosinophil Cationic Protein Variation in Patients with Asthma and CRSwNP Treated with Dupilumab
por: Ledda, Andrea Giovanni, et al.
Publicado: (2023)

Cost–Utility Analysis of Dupilumab for the Treatment of Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) in Italy
por: De Corso, Eugenio, et al.
Publicado: (2022)

Effectiveness of Dupilumab in the Treatment of Patients with Severe Uncontrolled CRSwNP: A “Real-Life” Observational Study in the First Year of Treatment
por: De Corso, Eugenio, et al.
Publicado: (2022)

Dupilumab in CRSwNP: Responder Analysis Using Clinically Meaningful Efficacy Outcome Thresholds
por: Chuang, Chien‐Chia, et al.
Publicado: (2021)

Efficacy of Biologics on Refractory Eosinophilic Otitis Media Associated with Bronchial Asthma or Severe Uncontrolled CRSwNP
por: De Corso, Eugenio, et al.
Publicado: (2022)

WITHDRAWN: Dupilumab: A review of potential in the treatment of Chronic rhinosinusitis with nasal polyps (CRSwNP)
por: Sree Sudha, T.Y., et al.
Publicado: (2020)

Real-life effectiveness of dupilumab in patients with mild to moderate bronchial asthma comorbid with CRSwNP
por: Minagawa, Shunsuke, et al.
Publicado: (2022)

The “real life” efficacy of dupilumab is independent of initial polyp size and concomitant steroids in CRSwNP
por: Campion, Nicholas J., et al.
Publicado: (2023)

EUFOREA consensus on biologics for CRSwNP with or without asthma
por: Fokkens, Wytske J., et al.
Publicado: (2019)

Real-world evidence for the effectiveness and safety of dupilumab in patients with CRSwNP after 1 year of therapy
por: Albrecht, Tobias, et al.
Publicado: (2023)

Targeting IL-4 and IL-13 Receptors on Eosinophils in CRSwNP Patients: The Clinical Efficacy of Dupilumab
por: Piazzetta, Giovanna Lucia, et al.
Publicado: (2023)

The argument against the use of dupilumab in patients with limited polyp burden in chronic rhinosinusitis with nasal polyposis (CRSwNP)
por: Hardison, Scott A., et al.
Publicado: (2023)

Computational fluid dynamic modeling of the effect of dupilumab in the management of anosmia secondary to chronic rhinosinusitis with nasal polyps (CRSwNP)
por: Lepley, Thomas J., et al.
Publicado: (2022)

Clinical characteristics of patients with CRSwNP with intensely high eosinophil level
por: Ma, Ling, et al.
Publicado: (2022)

Adverse events for biologics in patients with CRSwNP: A meta‐analysis
por: Shen, Yang, et al.
Publicado: (2022)

Profiling Disease and Economic Burden in CRSwNP Using Machine Learning
por: Bhattacharyya, Neil, et al.
Publicado: (2022)

Nasal cytology and histology in CRSwNP: Two sides of the same coin
por: Gelardi, Matteo, et al.
Publicado: (2023)

Differences in men and women suffering from CRSwNP and AERD in quality of life
por: Bartosik, Tina J., et al.
Publicado: (2020)

Guideline for the use of immunobiologicals in chronic rhinosinusitis with nasal polyps (CRSwNP) in Brazil
por: Anselmo-Lima, Wilma T., et al.
Publicado: (2021)

Calprotectin in nasal secretion: a new biomarker of non-type 2 inflammation in CRSwNP
por: De Corso, Eugenio, et al.
Publicado: (2022)

Comparison of different medical treatment options for CRSwNP: doxycycline, methylprednisolone, mepolizumab and omalizumab
por: De Schryver, Els, et al.
Publicado: (2015)

Real‐life effectiveness of biological therapies on symptoms in severe asthma with comorbid CRSwNP
por: Mümmler, Carlo, et al.
Publicado: (2021)

Necroptosis Underlies Neutrophilic Inflammation Associated with the Chronic Rhinosinusitis with Nasal Polyps (CRSwNP)
por: Xie, Yadong, et al.
Publicado: (2021)

Eosinophil-mast cell pattern of intraepithelial infiltration as a marker of severity in CRSwNP
por: Gelardi, Matteo, et al.
Publicado: (2023)

How to manage recurrences after surgery in CRSwNP patients in the biologic era: a narrative review
por: De Corso, Eugenio, et al.
Publicado: (2023)

Epithelial immune regulation of inflammatory airway diseases: Chronic rhinosinusitis with nasal polyps (CRSwNP)
por: Klimek, Ludger, et al.
Publicado: (2022)

Checklist for the Multidisciplinary Approach to United Airway in Patients with Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) and asthma
por: Castillo Vizuete, José Antonio, et al.
Publicado: (2022)

A retrospective, cross-sectional study reveals that women with CRSwNP have more severe disease than men
por: Stevens, Whitney W, et al.
Publicado: (2015)

A Randomized Clinical Trial of Elemental Zinc Add-on Therapy on Clinical Outcomes of Patients with Chronic Rhinosinusitis with Nasal Polyposis (CRSwNP)
por: Akbari Dilmaghani, Nader, et al.
Publicado: (2019)

Are objective ‘findings’ the same as subjective ‘severity’? A study of the relationship between computed tomography findings and subjective severity in preoperative CRSwNP patients
por: Lu, Hanyu, et al.
Publicado: (2020)

Management of Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) in the Pan-Arab Region: Consensus Recommendations from a Multidisciplinary Expert Working Group
por: Marglani, Osama, et al.
Publicado: (2023)

The efficacy and safety of several interventions of corticosteroids for CRSwNP patients after endoscope sinus surgery: A protocol for systematic review and network meta-analysis
por: Zhang, Lan, et al.
Publicado: (2022)

P123 Study of naïve and memory T helper cell response in patients of chronic rhinosinusitis with nasal polyposis (CRSwNP) after in vitro exposure to Aspergillus flavus
por: Das, Shukla, et al.
Publicado: (2022)

Spotlight on a Short-Time Treatment with the IL-4/IL-13 Receptor Blocker in Patients with CRSwNP: microRNAs Modulations and Preliminary Clinical Evidence
por: Mimmi, Selena, et al.
Publicado: (2022)

Expression of Apoptosis-Related Biomarkers in Inflamed Nasal Sinus Epithelium of Patients with Chronic Rhinosinusitis with Nasal Polyps (CRSwNP)—Evaluation at mRNA and miRNA Levels
por: Morawska-Kochman, Monika, et al.
Publicado: (2022)

The SMYD3-dependent H3K4me3 status of IGF2 intensifies local Th2 differentiation in CRSwNP via positive feedback
por: Yu, Lei, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_pmkaeveuug00v6verkovilc236